Rajiv Agarwal
Nephrology · Indianapolis, INNPI 1154386258
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,103,835 of the $1,217,870 with a category attached, or 90.6%. 18 manufacturers reported payments, led by Bayer at 28.3% of the total. Among nephrology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 569 payments — averaging $2140.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$344K
- Vertex$268K
- Alnylam Pharmaceuticals Inc.$176K
- Akebia Therapeutics Inc$79K
- Boehringer Ingelheim International GmbH$67K
- Vifor Pharma, Inc.$62K
- plus $223K from 12 others
Across 89 payments — averaging $3310.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$160K
- Intercept Pharmaceuticals, Inc.$110K
- Novartis$25K
What the payments were for
- Consulting fees$1,103,83591%
- Speaking & faculty fees$7,8631%
- Travel & lodging$99,1188%
- Food & beverage$7,0351%
- Education$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 236 | $344,347 |
| Vertex | 108 | $267,919 |
| Alnylam Pharmaceuticals Inc. | 32 | $175,600 |
| Akebia Therapeutics Inc | 23 | $78,564 |
| Boehringer Ingelheim International GmbH | 31 | $66,795 |
| Vifor Pharma, Inc. | 34 | $62,107 |
| Intercept Pharmaceuticals, Inc. | 6 | $59,400 |
| AstraZeneca(2 entities) | 15 | $34,860 |
| Novartis | 23 | $34,770 |
| Janssen Research & Development, LLC | 16 | $30,868 |
| Vifor Fresenius Medical Care Renal Pharma Ltd. | 16 | $27,989 |
| Eli Lilly | 3 | $9,350 |
| Boehringer Ingelheim | 11 | $7,971 |
| Merck | 9 | $6,958 |
| Sanofi US Services Inc. | 2 | $3,290 |
| Astrazeneca UK Limited | 2 | $2,750 |
| Astrazeneca AB | 1 | $2,500 |
| Chugai Pharmaceutical Co., Ltd. | 1 | $1,830 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,217,870 in reported general payments places this provider in the 95th percentile of 238 nephrology providers in Indiana.
Other nephrology in Indianapolis
- Jay WishIndianapolis$502K
- Bruce MolitorisIndianapolis$108K
- Michael KrausIndianapolis$92K
- Muhammad MujtabaIndianapolis$71K
- Simit DoshiIndianapolis$63K
- Arjun SinhaIndianapolis$50K
- Brent MillerIndianapolis$46K
- James ElliottIndianapolis$37K
- Nupur GuptaIndianapolis$20K
- Judith MaddatuIndianapolis$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.